Weight-loss drugs linked to lower depression and anxiety risk, study

GLP-1 weight-loss drugs with semaglutide were associated with a lower risk of depression, anxiety, substance use disorders, and self-harm, according to a new study. Semaglutide, a common ingredient in GLP-1 weight-loss medications, is associated with lower risks of worsening mental disorders,…